Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
8-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Issue 8-3
News Flashes
advertisement
News Flashes
IGR 8-3
The prevalence of all glaucoma was 3.8% including 2.1% of POAG and 1.5% of PACG in the Liwan district in Guangzhou
Patients rated the risk of being unable to drive the highest in importance (mean of 39%), followed by the risk of blindness (mean of 27%)
It is now possible to use AAV based vector systems for TM gene delivery and this is a significant advance in gene therapy for glaucoma
Conventional SITA-fast-SAP was NOT significantly less sensitive than SITA-SWAP and full-threshold-SWAP programs�
There is a population of viable RGCs (within the central retina) that are dysfunctional in early glaucoma
Asymmetry of retinal sensitivity and of IOP are additional risk factors for conversion (OHTS)
The majority of glaucoma (60%) has a familial basis
There is no association between glaucoma and mortality from all-causes
For the first time, a genetic component related to the circadian rhythm of IOP has been identified
Subjects with diastolic blood pressure (DBP) lower than 90 mmHg as a result of antihypertensive therapy had significantly thinner neuroretinal rim measurements and larger values of cup area compared to subjects with high DBP (≥ 90 mmHg)
Between 27% and 53% of OHT showed either VF or OD progression over 6 years
ALT treated eyes have less of a hypotensive response to latanoprost than those who have not been treated with ALT
An elevation of thymulin in the serum of POAG patients was found
Issue
8-3
Table of Contents
Editor's Selection
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement
